INDEPENDENT INTELLIGENCE
LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

AN2 Therapeutics, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERANTX
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / ANTX COVERAGE

What’s moving AN2 Therapeutics, Inc. now

Current reporting with the operating signal separated from the noise.

01
AN2 Therapeutics, Inc. (ANTX) Presents at Leerink Global Healthcare Conference 2026 Transcript

AN2 Therapeutics, Inc. (ANTX) Presents at Leerink Global Healthcare Conference 2026 Transcript

The story matters when it changes AN2 Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest ANTX filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-11 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-12 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-17 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-06-09 · Period 2026-06-03SEC ↗8-KMaterial company eventFiled 2026-06-04 · Period 2026-06-04SEC ↗8-KMaterial company eventFiled 2026-05-11 · Period 2026-05-11SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-22 · Period 2026-04-22SEC ↗4Official SEC filingFiled 2026-07-10 · Period 2026-07-10SEC ↗
EARNINGS / QUARTERLY TRACKER

AN2 Therapeutics, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.